Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.

I was diagnosed with stage 3 melanoma at 31, faced recurrence and now share my journey to raise awareness, stay hopeful and ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology ...

It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and ...

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS ...

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS ...

The first patient has been dosed in a phase 1 clinical trial of CT-95 among patients with mesothelin-expressing solid tumors.

Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly ...